Source link : https://newshealth.biz/health-news/first-once-weekly-basal-insulin-approved-for-type-2-diabetes/
The FDA approved insulin icodec (Awiqli) as the first once-weekly, long-acting basal insulin for glycemic control in adults with type 2 diabetes, developer Novo Nordisk announced. Of note, the agency rejected the product in 2024 for type 1 diabetes, where it is still not indicated. Designed to reduce treatment burden as an alternative to daily […]
The post First Once-Weekly Basal Insulin Approved for Type 2 Diabetes first appeared on News Health.
—-
Author : News Health
Publish date : 2026-03-27 20:21:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8